Groww Logo
Home>US Stocks>ABIOMED Inc
A

ABIOMED Inc

Healthcare
$254.29
+ $5.10 (2.05%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $247.85$249.19346,699347,462

      Fundamentals

      Market Cap$11.58B
      P/B Ratio7.7
      P/E Ratio84.9
      Enterprise Value$11.45B
      Div. Yield0.00%
      Book Value33.08
      EPS(TTM)3.00
      ROE9.70%
      Understand Fundamentals

      About the Company

      Since its inception in 1981, Abiomed Inc. has introduced advanced and beneficial technologies for patients and physicians alike. It is a pioneer and global leader in the healthcare industry. The company has its headquarters in Massachusetts, USA, wit
      Since its inception in 1981, Abiomed Inc. has introduced advanced and beneficial technologies for patients and physicians alike. It is a pioneer and global leader in the healthcare industry. The company has its headquarters in Massachusetts, USA, with offices in various locations around the globe, including two in Germany and one in Japan. Abiomed was founded with a motive to develop the first artificial human heart. The company accomplished this goal and introduced AbioCor, the world’s first completely self-contained, implantable artificial heart. It was successfully transplanted to a patient in 2001. Subsequently, more such transplants were carried out. On September 5th 2006, this device received approval from the Food and Drugs Administration (FDA). In 2005, the company acquired Impella CardioSystems AG of Germany, maker of Impella – the world’s smallest heart pump. With this acquisition, its focus shifted from heart replacement to recovery. These devices are available in a variety of ranges, with some of them receiving FDA approvals in the US. Times Magazine awarded AbioCor the Best Invention of the Year award in 2001. The company ranked 64 among the 2000 Global Growth Champions list by Forbes in 2018. It was also added to the S&P 500 index in this same year. In 2019, Abiomed ranked 19th on the Fortune magazine’s list of 100 fastest-growing companies. It held the 4th position in Barron’s ranking of the best-performing stocks of the 2010s. Furthermore, on 25th March 2020, Abiomed announced its strategies to aid the global medical community and improved patient care during Covid-19 outbreak. Abiomed Inc. is a leading provider of circulatory support to patients. It engages in research, development and sale of medical devices catering to the care of patients with heart issues. Its products are designed to assist a failing heart, thus improving the blood flow. Over years, Abiomed has remained dedicated in serving the global healthcare community through sincere efforts and a mission of ‘recovering hearts and saving lives’.
      ...Read more
      OrganisationABIOMED Inc
      IndustryMedical Devices
      HeadQuartersDanvers, MA

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on ABIOMED Inc

      Can I Buy ABIOMED Inc Shares in India?

      Yes, ABIOMED Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy ABIOMED Inc Shares in India?

      One can easily invest in ABIOMED Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ABIOMED Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ABIOMED Inc.

      What is the Share Price of ABIOMED Inc?

      The share price of ABIOMED Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current ABIOMED Inc share price is $254.29 as of 25 May ‘22

      What is the Market Cap of ABIOMED Inc?

      The ABIOMED Inc market cap is $11.58B as of 25 May ‘22

      What is the PE and PB ratio of ABIOMED Inc?

      The PE and PB ratio of ABIOMED Inc is 84.9 and 7.7 as of 25 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.4.0
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW